Radiation combined with KRAS-MEK inhibitors enhances anticancer immunity in KRAS-mutated tumor models [CT26 RNA-seq]
Ontology highlight
ABSTRACT: KRAS mutation is a common driver in solid tumors, and KRAS-mutated tumors are relatively resistant to radiotherapy. Therefore, we investigated the combined effect of radiation and KRAS-MEK inhibitors (AMG510 and trametinib) in KRAS-mutated tumors.
ORGANISM(S): Mus musculus
PROVIDER: GSE209765 | GEO | 2022/10/01
REPOSITORIES: GEO
ACCESS DATA